New standards of medical care and clinical guidelines published in Russia in May 2021

03

Jun 2021

In Russia, standards of medical care are approved on the basis of the clinical guidelines and include average frequencies of the provision of procedures, devices, and drugs. In May 2021, two clinical guidelines and several standards of medical care were released. 

New standards of medical care that were published in May 2021 include:

  • Standards of medical care for adults with laryngopharyngeal cancer (link)
  • Standards of medical care for adults with paranasal sinus and nasal cavity cancer (link)
  • Standards of medical care for adults with laryngeal cancer (link)
  • Standards of medical care for adults with nasopharyngeal cancer (link)
  • Standards of medical care for adults with oropharyngeal cancer (link)
  • Standards of medical care for adults with retroperitoneal sarcomas (link)
  • Standards of medical care for adults with malignant neoplasms of ascending, transverse, descending, rectosigmoid colon (link)
  • Standards of medical care for adults with squamous cell carcinoma of the anal canal and perianal skin (link)
  • Standards of medical care for adults with ovarian, fallopian tube, and primary peritoneal cancer (link)
  • Standards of medical care for adults with endometrial cancer and uterine sarcomas (link)
  • Standards of medical care for adults with non-epithelial ovarian cancer (link)

New clinical guidelines that were published in May 2021 include:

  • Male infertility (link)
  • Cystitis in women (link)

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.

The latest related news

18

Jun 2021

In May 2021, the National Institute for Health and Care Excellence (NICE) published five new Interventional Procedure Guidance (ex-situ machine perfusion for extracorporeal preservation of lungs for transplant, transvaginal laser therapy for stress urinary incontinence and for urogenital atrophy, electrohydraulic lithotripsy for difficult-to-treat bile duct stones, and permanent His-bundle pacemaker for heart failure), one new Medical Technologies Guidance (UroLift for benign prostatic hyperplasia), and two new Medtech Innovation Briefings (Axonics sacral neuromodulation system for faecal incontinence and KODEX-EPD for cardiac imaging during ablation of arrhythmias). Also, three clinical guidelines and two Medical Technologies Guidance were updated.

Read more

15

Jun 2021

The National Institute for Health and Care Excellence (NICE) is currently developing health technology assessments concerning in-vitro diagnostics in its Diagnostic Guidance and Medtech Innovation Briefing programs. As of June 08, 2021, there are ten ongoing assessments.

Read more

10

Jun 2021

In May 2021, the Agency for Health Quality and Assessment of Catalonia (AQuAS) published a report on next-generation sequencing (NGS) for molecular diagnosis and selection of therapeutic targets in oncological diseases. The studies identified present favorable results on the diagnostic efficacy of the NGS-based gene panels; the evidence on the clinical effectiveness of NGS panels remains limited. The authors emphasize the need for further studies.

Read more

28

May 2021

In April 2021, the National Institute for Health and Care Excellence (NICE) published three new Interventional Procedure Guidance (repetitive short-pulse transscleral cyclophotocoagulation for glaucoma, deep brain stimulation for chronic, severe, treatment-resistant obsessive-compulsive disorder in adults, and Melphalan chemosaturation for primary or metastatic cancer in the liver) and two Medtech Innovation Briefings (microINR for anticoagulation therapy and RenalSense Clarity RMS for acute kidney injury), and two clinical guidelines (for atrial fibrillation and chronic pain in over 16s).

Read more

27

May 2021

In April 2021, the Austrian Institute for Health Technology Assessment (AIHTA) initiated several new research projects. The projects are related to IVD tests for early detection of colon cancer, telemedical care in diabetes field, health apps, screening methods, consequences of coronavirus pandemic, and other topics.

Read more